Combining feature selection and shape analysis uncovers precise rules for miRNA regulation in Huntington's disease mice.


Journal

BMC bioinformatics
ISSN: 1471-2105
Titre abrégé: BMC Bioinformatics
Pays: England
ID NLM: 100965194

Informations de publication

Date de publication:
24 Feb 2020
Historique:
received: 29 01 2020
accepted: 17 02 2020
entrez: 26 2 2020
pubmed: 26 2 2020
medline: 25 4 2020
Statut: epublish

Résumé

MicroRNA (miRNA) regulation is associated with several diseases, including neurodegenerative diseases. Several approaches can be used for modeling miRNA regulation. However, their precision may be limited for analyzing multidimensional data. Here, we addressed this question by integrating shape analysis and feature selection into miRAMINT, a methodology that we used for analyzing multidimensional RNA-seq and proteomic data from a knock-in mouse model (Hdh mice) of Huntington's disease (HD), a disease caused by CAG repeat expansion in huntingtin (htt). This dataset covers 6 CAG repeat alleles and 3 age points in the striatum and cortex of Hdh mice. Remarkably, compared to previous analyzes of this multidimensional dataset, the miRAMINT approach retained only 31 explanatory striatal miRNA-mRNA pairs that are precisely associated with the shape of CAG repeat dependence over time, among which 5 pairs with a strong change of target expression levels. Several of these pairs were previously associated with neuronal homeostasis or HD pathogenesis, or both. Such miRNA-mRNA pairs were not detected in cortex. These data suggest that miRNA regulation has a limited global role in HD while providing accurately-selected miRNA-target pairs to study how the brain may compute molecular responses to HD over time. These data also provide a methodological framework for researchers to explore how shape analysis can enhance multidimensional data analytics in biology and disease.

Sections du résumé

BACKGROUND BACKGROUND
MicroRNA (miRNA) regulation is associated with several diseases, including neurodegenerative diseases. Several approaches can be used for modeling miRNA regulation. However, their precision may be limited for analyzing multidimensional data. Here, we addressed this question by integrating shape analysis and feature selection into miRAMINT, a methodology that we used for analyzing multidimensional RNA-seq and proteomic data from a knock-in mouse model (Hdh mice) of Huntington's disease (HD), a disease caused by CAG repeat expansion in huntingtin (htt). This dataset covers 6 CAG repeat alleles and 3 age points in the striatum and cortex of Hdh mice.
RESULTS RESULTS
Remarkably, compared to previous analyzes of this multidimensional dataset, the miRAMINT approach retained only 31 explanatory striatal miRNA-mRNA pairs that are precisely associated with the shape of CAG repeat dependence over time, among which 5 pairs with a strong change of target expression levels. Several of these pairs were previously associated with neuronal homeostasis or HD pathogenesis, or both. Such miRNA-mRNA pairs were not detected in cortex.
CONCLUSIONS CONCLUSIONS
These data suggest that miRNA regulation has a limited global role in HD while providing accurately-selected miRNA-target pairs to study how the brain may compute molecular responses to HD over time. These data also provide a methodological framework for researchers to explore how shape analysis can enhance multidimensional data analytics in biology and disease.

Identifiants

pubmed: 32093602
doi: 10.1186/s12859-020-3418-9
pii: 10.1186/s12859-020-3418-9
pmc: PMC7041117
doi:

Substances chimiques

Huntingtin Protein 0
MicroRNAs 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Subventions

Organisme : CHDI Foundation
ID : A-12273

Références

Biochem Biophys Res Commun. 2018 Jan 1;495(1):12-19
pubmed: 29080748
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
PLoS One. 2013;8(1):e54222
pubmed: 23349832
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
pubmed: 17991681
Neurochem Res. 2017 Feb;42(2):513-525
pubmed: 27900578
FEBS J. 2015 Jul;282(13):2411-23
pubmed: 25846153
Genome Biol. 2014;15(10):500
pubmed: 25344330
Cell Transplant. 2017 Feb 16;26(2):243-257
pubmed: 27677799
PLoS One. 2013 Jul 26;8(7):e70153
pubmed: 23922946
Obes Surg. 2018 Sep;28(9):2804-2810
pubmed: 29693219
Mol Brain. 2019 May 2;12(1):40
pubmed: 31046797
J Neurosci. 2008 Dec 31;28(53):14341-6
pubmed: 19118166
Neurobiol Dis. 2008 Mar;29(3):438-45
pubmed: 18082412
J Neurosci. 2014 Jan 15;34(3):717-25
pubmed: 24431430
Nat Neurosci. 2016 Apr;19(4):623-33
pubmed: 26900923
PLoS Genet. 2011 Jun;7(6):e1001393
pubmed: 21695224
Neuropharmacology. 2017 Jan;112(Pt B):297-306
pubmed: 27245499
Bioinformatics. 2009 Oct 15;25(20):2625-31
pubmed: 19692556
Exp Neurol. 2009 Oct;219(2):424-9
pubmed: 19576215
Mol Cell Proteomics. 2002 Apr;1(4):304-13
pubmed: 12096112
Mol Med Rep. 2018 Sep;18(3):2857-2865
pubmed: 30015953
Nucleic Acids Res. 2017 Apr 20;45(7):e51
pubmed: 27986855
Mol Neurobiol. 2018 Jun;55(6):5232-5242
pubmed: 28879407
Mol Med Rep. 2017 Aug;16(2):2199-2204
pubmed: 28656195
BMC Genomics. 2009 Aug 11;10:373
pubmed: 19671175
PLoS One. 2010 Nov 29;5(11):e15497
pubmed: 21124738
ACS Chem Neurosci. 2016 Nov 16;7(11):1585-1594
pubmed: 27609046
Sci Rep. 2017 Feb 13;7:42297
pubmed: 28205572
Neuron. 2018 Sep 19;99(6):1145-1154.e6
pubmed: 30197236
BMC Genomics. 2016 May 17;17:364
pubmed: 27189211
Int J Mol Med. 2014 Jun;33(6):1407-14
pubmed: 24647639
J Mol Neurosci. 2018 Dec;66(4):617-628
pubmed: 30415446
Eur J Neurosci. 2011 May;33(9):1587-97
pubmed: 21447094
Bioinformatics. 2018 Nov 15;34(22):3781-3787
pubmed: 29868708
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5449-5455
pubmed: 31298398
Cell Death Dis. 2013 Jun 06;4:e651
pubmed: 23744351
Nucleic Acids Res. 2017 Jan 25;45(2):726-738
pubmed: 27924031
Bioinformatics. 2019 May 09;:
pubmed: 31070735
Cell Res. 2017 Jul;27(7):882-897
pubmed: 28429770
BMC Syst Biol. 2007 Nov 21;1:54
pubmed: 18031580
Nucleic Acids Res. 2017 Sep 6;45(15):8745-8757
pubmed: 28911111
Sci Rep. 2017 Aug 15;7(1):8269
pubmed: 28811646
Mol Med Rep. 2013 Dec;8(6):1741-6
pubmed: 24100613
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8191-6
pubmed: 24847069
Am J Transl Res. 2017 May 15;9(5):2473-2491
pubmed: 28559998
BMC Genomics. 2008 May 23;9:246
pubmed: 18501003
J Comput Biol. 2007 Jun;14(5):550-63
pubmed: 17683260
BMC Bioinformatics. 2010 May 28;11:292
pubmed: 20509939
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Stem Cells. 2013 Dec;31(12):2737-46
pubmed: 23630198
Pharmacol Res. 2016 Jun;108:102-110
pubmed: 27155059
Mol Cell Biol. 2018 May 29;38(12):
pubmed: 29610152
Exp Neurol. 2011 Jan;227(1):172-9
pubmed: 21035445
Dev Dyn. 2008 Nov;237(11):3387-93
pubmed: 18942138
Brief Bioinform. 2015 Sep;16(5):780-94
pubmed: 25471818
Curr Genomics. 2013 Apr;14(2):91-110
pubmed: 24082820
Cell Physiol Biochem. 2015;35(1):246-58
pubmed: 25591767
Front Neurosci. 2014 Nov 06;8:331
pubmed: 25414627
Genomics. 2012 Apr;99(4):189-94
pubmed: 22349176
Bioinformatics. 2016 Sep 15;32(18):2768-75
pubmed: 27207945
J Biomed Inform. 2014 Dec;52:438-47
pubmed: 25181465
J Neurosci. 2010 Mar 24;30(12):4428-39
pubmed: 20335479
Int J Mol Med. 2019 Mar;43(3):1167-1178
pubmed: 30628668
Arch Toxicol. 2016 Jan;90(1):191-202
pubmed: 25238743
Bioinformatics. 2013 Mar 15;29(6):765-71
pubmed: 23365408
Cytoskeleton (Hoboken). 2015 Jul;72(7):340-8
pubmed: 26257190
Genome Biol. 2010;11(8):R90
pubmed: 20799968
PLoS One. 2018 Jan 11;13(1):e0190550
pubmed: 29324753
Brain Struct Funct. 2017 Dec;222(9):4283-4291
pubmed: 28836069
Bioinformatics. 2010 May 15;26(10):1340-7
pubmed: 20385727
Neurobiol Aging. 2017 Feb;50:167.e1-167.e10
pubmed: 27816213
J Cell Biochem. 2019 Oct;120(10):17555-17565
pubmed: 31134678
PLoS Comput Biol. 2008 Aug 15;4(8):e1000117
pubmed: 18704157

Auteurs

Lucile Mégret (L)

Sorbonne Université, CNRS UMR8256, INSERM ERL U1164, Brain-C Lab, Paris, France. lucile.megret@sorbonne-universite.fr.

Satish Sasidharan Nair (SS)

Sorbonne Université, CNRS UMR8256, INSERM ERL U1164, Brain-C Lab, Paris, France.

Julia Dancourt (J)

Sorbonne Université, CNRS UMR8256, INSERM ERL U1164, Brain-C Lab, Paris, France.

Jeff Aaronson (J)

CHDI Foundation, Princeton, NJ, USA.

Jim Rosinski (J)

CHDI Foundation, Princeton, NJ, USA.

Christian Neri (C)

Sorbonne Université, CNRS UMR8256, INSERM ERL U1164, Brain-C Lab, Paris, France. christian.neri@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH